Method of detecting likelihood of suffering from prostate cancer
Provided is a prostate cancer detection technique. A method of detecting the likelihood of suffering from prostate cancer includes (1) subjecting a sample of bodily fluid collected from a subject, selected from the group consisting of dimethyl glutarate, 2, 6-dimethylaniline, 2-hydroxy-2-methyl prop...
Saved in:
Main Authors | , , , , , |
---|---|
Format | Patent |
Language | Chinese English |
Published |
19.09.2023
|
Subjects | |
Online Access | Get full text |
Cover
Summary: | Provided is a prostate cancer detection technique. A method of detecting the likelihood of suffering from prostate cancer includes (1) subjecting a sample of bodily fluid collected from a subject, selected from the group consisting of dimethyl glutarate, 2, 6-dimethylaniline, 2-hydroxy-2-methyl propiophenone, 2, 6-bis (propyl-2-yl) phenol, dimethyl succinate, acetophenone, 2-phenyl-2-propanol, and 3, 5, 6-trimethyl-1, 3, 5-trimethyl-1, 3, 5-trimethyl-1, 3, 5-trimethyl-1, 3, 5-trimethyl-1, 3, 5-trimethyl-1, 3, 5-trimethyl-1, 3, 5-trimethyl-1, 3, 5-trimethyl-1, 3, 5-trimethyl-1, 3, 5-trimethyl-1, 3- and a step for measuring the amount or concentration of at least one type of biomarker selected from among 2, 3, 5-trimethyl-2-cyclohexenone and 2, 3, 5-trimethyl-2-cyclohexenone.
提供一种前列腺癌的检测技术。一种检测前列腺癌的罹患可能性的方法,其包括(1)对从受检体采集的体液试样中的、选自戊二酸二甲酯、2,6-二甲基苯胺、2-羟基-2-甲基苯丙酮、2,6-二(丙-2-基)苯酚、琥珀酸二甲酯、苯乙酮、2-苯基-2-丙醇和3,5,5-三甲基-2-环己烯酮中的至少1种生物标志物的量或浓度进行测定的工序。 |
---|---|
Bibliography: | Application Number: CN20218089607 |